SCHEMBL4031864

SCHEMBL4031864

Cc1ccc(NC(=O)NCC#Cc2ccc(OC(C)C)c(C(=O)N[C@](C)(O)Cc3c[nH]c4ccccc34)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
PTGS2 P35354 1/20 0.39
HDAC8 Q9BY41 2/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CCKBR P32239 3/20 0.39
STING1 Q86WV6 1/20 0.38
NMBR P28336 1/20 0.37
GRPR P30550 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3942217 0.85 MAPT (0.43) MAPTSMN1; SMN2PTGS2HDAC8HDAC3
SCHEMBL4035462 0.84 KMT2A (0.41) MAPTPTGS2MEN1KMT2ANMBR
SCHEMBL4038448 0.83 KMT2A (0.42) MAPTPTGS2MEN1KMT2ANMBR
SCHEMBL4037073 0.82 KMT2A (0.39) MAPTMEN1KMT2ATACR1
SCHEMBL4031860 0.81 STING1 (0.39) MAPTSMN1; SMN2PTGS2HDAC8HDAC3
SCHEMBL4031866 0.81 STING1 (0.39) MAPTSMN1; SMN2PTGS2HDAC8HDAC3
SCHEMBL4033975 0.81 MAPT (0.39) MAPTMEN1KMT2ANMBRTACR1
SCHEMBL4034270 0.78 KMT2A (0.46) MAPTMEN1KMT2ANMBRPOLB
SCHEMBL3947792 0.75 MMP9 (0.43) MAPTMEN1KMT2APOLBTACR1
SCHEMBL13904509 0.75 MMP9 (0.43) MAPTMEN1KMT2APOLBTACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2019102-A1 Alkylacetylene substituted Acyltryptophanols Bayer Schering Pharma AG (DE) 2009-01-28 EP disclosed